Tumor Debulking in Multiorgan Metastatic Colorectal Cancer Fails to Improve Survival
Combining tumor debulking with palliative chemotherapy in multiorgan metastatic colorectal cancer does not enhance patient survival.
Newsletter
Every new paper in this field, in your inbox.
Combining tumor debulking with palliative chemotherapy in multiorgan metastatic colorectal cancer does not enhance patient survival.
Total neoadjuvant therapy (TNT) with short-course radiotherapy shows promise for locally advanced rectal cancer patients.
This study shows that circulating tumor DNA (ctDNA) can accurately reflect the genetic profile of appendiceal cancer, which is crucial for surgical decision-making.
Surgical intervention for liver metastases in colorectal cancer is underutilized among disadvantaged groups, impacting outcomes.
Using powered circular staplers in left-sided colorectal anastomoses does not significantly reduce anastomotic leaks compared to manual staplers.
Endoscopic closure may be a viable first-line approach for select iatrogenic colonic perforations.
Perioperative carcinoembryonic antigen (CEA) is a key marker for predicting survival and guiding treatment in stage II and III colorectal cancer.
Multimodal prehabilitation didn’t show significant benefits for postoperative outcomes in a diverse surgical population.
Colovac 2 may reduce the need for diverting ostomies after low anterior resection.
Endorobotic submucosal dissection (ERSD) using the da Vinci SP system is a safe and effective option for resecting distal colorectal lesions.